Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
about
Trial Watch: Proteasomal inhibitors for anticancer therapyModelling proteasome and proteasome regulator activities.New insights into the treatment of multiple myeloma with histone deacetylase inhibitors.Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain.Balancing novelty with confined chemical space in modern drug discovery.Inflammaging and cancer: a challenge for the Mediterranean dietQuantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomesProteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopesCurrent understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.Methods for 20S Immunoproteasome and 20S Constitutive Proteasome Determination Based on SPRI Biosensors.Towards a liquid self: how time, geography, and life experiences reshape the biological identity.Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.Immunity and Inflammation in Epilepsy.Mediterranean diet and inflammaging within the hormesis paradigm.Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation.
P2860
Q28082910-09406F1A-1E17-41F1-90E6-3502946EC189Q33912642-468BE8B3-7999-45D8-8A6C-799F8207CA59Q34224278-3F4A5503-5C93-4C2B-875E-F9C3DF929DA9Q34718525-E292A7A2-11C7-4C36-A829-01018CA6FBF4Q35071339-BFF08DB0-AB63-499E-9CCE-194BED36FCF0Q35585943-E5F95FA0-AFC7-4008-A919-C568B4C96D54Q36177598-92310FE5-DDB7-4C61-AD6D-FB87AA697F46Q36769053-5FFCF263-9BD3-4A62-92A8-2D7E865292A5Q37541906-5A7DD30A-5929-4172-9B88-AA9EF7284B57Q37690125-696A7DE2-DCAA-43CB-8A2A-5126F3D91CECQ37703203-6BE9FBB6-6480-4303-9D04-0A68C75AC4A8Q37705431-818335F6-AF36-4C2F-A8A3-5A85F745F8EEQ37727613-870A5F1E-A6C9-43FA-9AA5-F3EA258837EAQ38673807-B61C5080-0945-4A76-B4DE-5E2CE6363A9AQ38736064-086692BB-579A-4890-8B50-69B89942537EQ38955527-EBA705EA-8F11-4F56-B168-CCE73AFA22AA
P2860
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
@en
type
label
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
@en
prefLabel
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
@en
P2093
P50
P1476
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
@en
P2093
Agostino Baruzzi
Elena Bellavista
Federico Andreoli
Marco Daniele Parenti
Miriam Capri
Morena Martucci
Stefano Salvioli
P304
P356
10.2174/138161213804581927
P577
2013-01-01T00:00:00Z